Insulin Detemir [inzulin detemir]
topical
30
- Terms
-
B29-tetradekanoyl-Lys-B30-des-Ala-insulin
insulin detemir
Levemir
-
12C-Lys(B29)-DB30I
B29-tetradecanoyl-Lys-B30-des-Ala-insulin
Basal Insulin Detemir
Des-(B30)-insulin, Lys(B29)-tetradecanoyl
Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30)
Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30)
Levemir
NN 304
NN-304
NN304
Persistent link
https://www.medvik.cz/link/D000069057
Definition
A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.
- DUI
- D000069057 MeSH Browser
- CUI
- M0274330
- History note
- 2016 (1997)
- Public note
- 2016; INSULIN DETEMIR was indexed under INSULIN, LONG-ACTING 2011-2015; under INSULIN 1997-2011; and under CARRIER PROTEINS 1997-2004
Allowable subheadings
- AD
- administration & dosage 16
- AE
- adverse effects 3
- AA
- analogs & derivatives
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 11
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D06.472.699.587.200.300.300
Insulin, Lente
D12.644.548.586.200.300.300
Insulin, Lente